Your browser doesn't support javascript.
loading
Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report-IVY Network, February 1-August 31, 2022.
Surie, Diya; Bonnell, Levi N; DeCuir, Jennifer; Gaglani, Manjusha; McNeal, Tresa; Ghamande, Shekhar; Steingrub, Jay S; Shapiro, Nathan I; Busse, Laurence W; Prekker, Matthew E; Peltan, Ithan D; Brown, Samuel M; Hager, David N; Ali, Harith; Gong, Michelle N; Mohamed, Amira; Khan, Akram; Wilson, Jennifer G; Qadir, Nida; Chang, Steven Y; Ginde, Adit A; Huynh, David; Mohr, Nicholas M; Mallow, Christopher; Martin, Emily T; Lauring, Adam S; Johnson, Nicholas J; Casey, Jonathan D; Gibbs, Kevin W; Kwon, Jennie H; Baughman, Adrienne; Chappell, James D; Hart, Kimberly W; Grijalva, Carlos G; Rhoads, Jillian P; Swan, Sydney A; Keipp Talbot, H; Womack, Kelsey N; Zhu, Yuwei; Tenforde, Mark W; Adams, Katherine; Self, Wesley H; McMorrow, Meredith L.
Afiliação
  • Surie D; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: dsurie@cdc.gov.
  • Bonnell LN; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States; General Dynamics Information Technology, Falls Church, VA, United States.
  • DeCuir J; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Gaglani M; Baylor Scott & White Health and Texas A&M University College of Medicine, Temple, TX, United States.
  • McNeal T; Baylor Scott & White Health and Texas A&M University College of Medicine, Temple, TX, United States.
  • Ghamande S; Baylor Scott & White Health and Texas A&M University College of Medicine, Temple, TX, United States.
  • Steingrub JS; Department of Medicine, Baystate Medical Center, Springfield, MA, United States.
  • Shapiro NI; Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA, United States.
  • Busse LW; Department of Medicine, Emory University, Atlanta, GA, United States.
  • Prekker ME; Department of Emergency Medicine and Medicine, Hennepin County Medical Center, Minneapolis, MN, United States.
  • Peltan ID; Department of Medicine, Intermountain Medical Center, Murray, UT and University of Utah, Salt Lake City, UT, United States.
  • Brown SM; Department of Medicine, Intermountain Medical Center, Murray, UT and University of Utah, Salt Lake City, UT, United States.
  • Hager DN; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Ali H; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Gong MN; Department of Medicine, Montefiore Health System, Albert Einstein College of Medicine, Bronx, NY, United States.
  • Mohamed A; Department of Medicine, Montefiore Health System, Albert Einstein College of Medicine, Bronx, NY, United States.
  • Khan A; Department of Medicine, Oregon Health and Sciences University, Portland, OR, United States.
  • Wilson JG; Department of Emergency Medicine, Stanford University School of Medicine, Stanford, CA, United States.
  • Qadir N; Department of Medicine, University of California-Los Angeles, Los Angeles, CA, United States.
  • Chang SY; Department of Medicine, University of California-Los Angeles, Los Angeles, CA, United States.
  • Ginde AA; Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, United States.
  • Huynh D; Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, United States.
  • Mohr NM; Department of Emergency Medicine, University of Iowa, Iowa City, IA, United States.
  • Mallow C; Department of Medicine, University of Miami, Miami, FL, United States.
  • Martin ET; School of Public Health, University of Michigan, Ann Arbor, MI, United States.
  • Lauring AS; Departments of Internal Medicine and Microbiology and Immunology, University of Michigan, Ann Arbor, MI, United States.
  • Johnson NJ; Department of Emergency Medicine and Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, WA, United States.
  • Casey JD; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Gibbs KW; Department of Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.
  • Kwon JH; Department of Medicine, Washington University, St. Louis, MO, United States.
  • Baughman A; Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Chappell JD; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Hart KW; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Grijalva CG; Department of Health Policy, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Rhoads JP; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Swan SA; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Keipp Talbot H; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Womack KN; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Zhu Y; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, United States.
  • Tenforde MW; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Adams K; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Self WH; Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, United States; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, United States.
  • McMorrow ML; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Vaccine ; 41(29): 4249-4256, 2023 06 29.
Article em En | MEDLINE | ID: mdl-37301704
BACKGROUND: Accurate determination of COVID-19 vaccination status is necessary to produce reliable COVID-19 vaccine effectiveness (VE) estimates. Data comparing differences in COVID-19 VE by vaccination sources (i.e., immunization information systems [IIS], electronic medical records [EMR], and self-report) are limited. We compared the number of mRNA COVID-19 vaccine doses identified by each of these sources to assess agreement as well as differences in VE estimates using vaccination data from each individual source and vaccination data adjudicated from all sources combined. METHODS: Adults aged ≥18 years who were hospitalized with COVID-like illness at 21 hospitals in 18 U.S. states participating in the IVY Network during February 1-August 31, 2022, were enrolled. Numbers of COVID-19 vaccine doses identified by IIS, EMR, and self-report were compared in kappa agreement analyses. Effectiveness of mRNA COVID-19 vaccines against COVID-19-associated hospitalization was estimated using multivariable logistic regression models to compare the odds of COVID-19 vaccination between SARS-CoV-2-positive case-patients and SARS-CoV-2-negative control-patients. VE was estimated using each source of vaccination data separately and all sources combined. RESULTS: A total of 4499 patients were included. Patients with ≥1 mRNA COVID-19 vaccine dose were identified most frequently by self-report (n = 3570, 79 %), followed by IIS (n = 3272, 73 %) and EMR (n = 3057, 68 %). Agreement was highest between IIS and self-report for 4 doses with a kappa of 0.77 (95 % CI = 0.73-0.81). VE point estimates of 3 doses against COVID-19 hospitalization were substantially lower when using vaccination data from EMR only (VE = 31 %, 95 % CI = 16 %-43 %) than when using all sources combined (VE = 53 %, 95 % CI = 41 %-62%). CONCLUSION: Vaccination data from EMR only may substantially underestimate COVID-19 VE.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article